Results 171 to 180 of about 11,522 (222)

Fat embolism: a systematic review to facilitate the development of standardised procedures in pathology

open access: yesHistopathology, Volume 86, Issue 6, Page 845-861, May 2025.
The present study can provide a comprehensive overview of the FE topic. It furnishes pathologists with an updated overview useful for clinical practice and guiding future research trends, as well as facilitating the development of standardised procedures.
Donato Morena   +4 more
wiley   +1 more source

Development and validation of an enteral feeding interruption management scale for ICU medical staff: A knowledge‐, attitude‐ and practice‐based approach

open access: yesNursing in Critical Care, Volume 30, Issue 3, May 2025.
Abstract Background Enteral feeding interruption (EFI) is a frequent issue in ICU settings, affecting nutritional adequacy and delaying recovery in critically ill patients. While tools exist to assess patients' nutritional status, no instrument evaluates ICU staff's knowledge, attitude and practice (KAP) in EFI management. Aim To develop a reliable and
Yuanyuan Mi   +4 more
wiley   +1 more source

Elevated Linoleic Acid Intake Becomes a Risk Factor for Polycystic Ovary Syndrome by Affecting Ovarian Granulosa Cells

open access: yesThe FASEB Journal, Volume 39, Issue 7, 15 April 2025.
This study explored the relationship between dietary LA intake and PCOS. Animal experiments demonstrated that increased intake of LA led to PCOS‐like changes in mice, presenting with disordered estrous cycles, polycystic ovaries, and hyperandrogenism.
Wenying Zhang, Fuju Wu
wiley   +1 more source

Robust Systemic and Mucosal Immune Responses to Coxsackievirus B3 Elicited by Spider Silk Protein Based Nanovaccines via Subcutaneous Immunization

open access: yesAdvanced Functional Materials, Volume 35, Issue 15, April 10, 2025.
Spider minor ampullate silk protein (MiSp) and retinoic acid (RA) based nanovaccine are capable of eliciting both mucosal and systemic immune responses following subcutaneous administration and demonstrate significant protective effects against CVB3 infection in mice.
Xingmei Qi   +4 more
wiley   +1 more source

Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases

open access: yesAdvanced Science, Volume 12, Issue 13, April 3, 2025.
This article reviews the use of fecal microbiota transplantation (FMT) to treat intestinal diseases like recurrent Clostridioides difficile infection (rCDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). It discusses FMT's efficacy, influencing factors such as donor selection, recipient characteristics, and treatment protocols ...
Shuna Hou   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy